Literature DB >> 10975440

Molecular studies of beta-thalassemia heterozygotes with raised Hb F levels.

C Vrettou1, E Kanavakis, J Traeger-Synodinos, A Metaxotou-Mavrommati, I Basiakos, E Maragoudaki, A Stamoulakatou, I Papassotiriou, C Kattamis.   

Abstract

Hb F levels in beta-thalassemia heterozygotes are usually less than 2%, but amongst 1,059 patients studied, 73 (7%) had Hb F levels above 2.5% (2.6-14.0%). To investigate factors that may influence the increase of Hb F levels in these heterozygotes, we characterized the beta-thalassemia mutations and their chromosomal background, gamma-globin gene promoter variations, and alpha-globin genotypes. All 73 beta-thalassemia heterozygotes carried beta-thalassemia point mutations previously observed in the Greek population; gene mapping excluded b gene cluster deletions; only two cases had an additional gamma-globin gene (gammagammagamma/gammagamma). Five alpha-globin genes (alphaalphaalpha/alphaalpha) were detected in 17/73 cases (23%) as compared to a carrier rate of 1.76% in the general population. Molecular, hematological, and biosynthetic findings in these compound heterozygotes indicated that the raised Hb F levels were caused by cell selection due to ineffective erythropoiesis. In the remaining 56 simple beta-thalassemia heterozygotes, 11 beta-thalassemia mutations were observed, each on the expected haplotype(s), and analysis of the gamma gene promoters revealed three known polymorphisms (in linkage disequilibrium), with minimal influence on gamma-globin levels. However, the overall distribution of beta-thalassemia mutations in the 56 simple beta-thalassemia heterozygotes was significantly different (P<0.0002) compared to that in 986 simple beta-thalassemia heterozygotes with <2.5% Hb F, implicating an association between beta-thalassemia mutations and moderately increased Hb F levels, most notably codon 39 (C-->T), IVS-II-1 (G-->A), codon 6 (-A), and codon 8 (-AA), which accounted for 41/56 (73%) cases with >2.5% Hb F. In the remaining 15/56 (27%) cases, no common underlying globin genotypes could explain the raised Hb F levels. Overall, this study indicates that the control of Hb F levels in beta-thalassemia heterozygotes is heterogeneous and multi-factorial.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10975440     DOI: 10.3109/03630260008997528

Source DB:  PubMed          Journal:  Hemoglobin        ISSN: 0363-0269            Impact factor:   0.849


  4 in total

1.  Diagnostic Dilemma of HbA1c Detection in Presence of a Hemoglobinopathy: A Case Report.

Authors:  Vijay S Bhat; Kalyan Kumar Dewan; Patnam Rajagopalan Krishnaswamy
Journal:  Indian J Clin Biochem       Date:  2010-09-14

2.  Factors regulating Hb F synthesis in thalassemic diseases.

Authors:  Fabrizio Mastropietro; Guido Modiano; Maria Cappabianca; Enrica Foglietta; Carmelo D'Asero; Mauro Mezzabotta; Donatella Ponzini; Laura Maffei; Antonio Amato; Maria Lerone; Paola Grisanti; Paola Di Biagio; Silvana Rinaldi; Ida Bianco
Journal:  BMC Blood Disord       Date:  2002-02-06

3.  HBG2 -158 (C>T) polymorphism and its contribution to fetal hemoglobin variability in Iraqi Kurds with beta-thalassemia minor.

Authors:  Dilan J Albarawi; Amer A Balatay; Nasir Al-Allawi
Journal:  J Lab Physicians       Date:  2018 Oct-Dec

4.  Heterozygosity of the Complex Corfu δ0β+ Thalassemic Allele (HBD Deletion and HBB:c.92+5G&gt;A) Revisited.

Authors:  Christos Kattamis; Myrto Skafida; Polyxeni Delaporta; Christina Vrettou; Joanne Traeger-Synodinos; Christalena Sofocleous; Antonis Kattamis
Journal:  Biology (Basel)       Date:  2022-03-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.